15.09.2017
- AstraZeneca has agreed to sell the remaining rights to its anesthetic drugs portfolio to Aspen Global Incorporated (AGI) in a deal worth up to $766 million. The portfolio comprises...
02.12.2014
- Siegfried Group has acquired Hameln Pharma in Germany, consisting of Hameln Pharmaceuticals and Hameln RDS, with effect from end November 2014. Hameln Pharma is located in the city...
